Sign in
4

Changes in Ownership

Sionna Therapeutics, Inc. Filed Acc 0000947871-26-000587

Director sold 101 shares at $44.49 ($4,493)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ORBIMED ADVISORS LLC · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-27 Sale : show line 1 in the form 10b5-1 −101 $44.49 $4,493 2,671,721 I
Open-market sales · 101 sh · avg $44.49 · $4,493
Loading xslF345X06/ownership.xml…